The DEA has ordered drug companies to produce fewer opioids in 2017, due to the opioid addiction crisis and a decreasing demand for the drugs.
Poor training, impatience, and fear of malpractice suits keeps many doctors from reporting superbug deaths to the CDC. Yes, this is a problem.
Activists are urging Congress to require schools to test PCB levels following a Harvard study showing that up to 26,000 schools contain toxic levels.
On October 12, the DEA announced it would not ban kratom, an herb used as a natural medicine. Public comment on the ban will be open until December 1.
Antitobacco groups have filed a lawsuit against the FDA, which had vowed to put graphic warnings on cigarette packs by June 2011.
Both marijuana edibles and their packaging must now be labeled with “THC” in Colorado to make them look distinctive. Here is why.
In a first for the U.S., 7 species of bees native to Hawaii have been granted protection under the Endangered Species Act.
On September 30, the CDC issued fresh warnings for men and women regarding transmission of the Zika virus. Here is the scoop.
Air pollution is responsible for 11% of deaths worldwide. Air pollution is much worse in poorer countries than in developed, wealthier ones.
The FDA is seeking public comment on what the definition of “healthy” should be as it applies to foods. Current standards may surprise you.
Over 2,000 women have sued Johnson and Johnson over allegations that their talcum powder causes cancer. Now, another woman has come forward.
Like the pharmaceutical industry, the alcohol industry is fighting marijuana legalization over fears that legal weed would pose too much competition.
Greenpeace has discovered that Bayer and Syngenta hid research proving its neonicotinoid pesticides cause substantial harm to honeybees.
A study published on September 15 shows that in states where medical marijuana is legal, fewer people use opioid drugs.
People around the world are furious over Nestle’s latest escapade: buying a drought-stricken town’s water supply.
A marijuana-based childhood epilepsy drug has taken 1 step closer to approval after phase 3 clinical trial results kids had a 42% reduction in seizures.
Monsanto has licensed the CRISPR-Cas9 gene editing tool, which will allow the agritech giant to add and delete DNA from crops.